Zynerba Pharmaceuticals Announces New Date for Reconvened Annual Meeting

Annual Meeting to Reconvene on August 11, 2023 at 9:00 a.m. EDTDEVON, Pa., July 25, 2023 -- Zynerba Pharmaceuticals, Inc. , the leader in innovative pharmaceutically-produced transdermal...

Related Keywords

United States ,American ,Peter Vozzo ,American Stock Transfer Trust Company ,Nasdaq ,Company Proxy Statement For The Annual Meeting ,Board Of Directors The Company ,Zynerba Pharmaceuticals Inc ,Mackenzie Partners Inc ,Exchange Commission ,Certificate Of Incorporation The Company ,Zynerba Pharmaceuticals ,Company Board ,Annual Meeting ,Sixth Amended ,Restated Certificate ,American Stock Transfer ,Trust Company ,Proxy Statement ,Nasdaq Capital ,Nasdaq Capital Market ,Mackenzie Partners ,Private Securities Litigation Reform Act ,